en

PRODUCT DETAIL

Lamivudine Teva Pharma B.V. 300 mg filmom obalené tablety

Code 9726C
MA number EU/1/09/596/016
Product Form: tbl flm 80x300 mg (blis.PVC/PVDC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
J05AF05 Lamivudine
Shelf life: 24
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 10.12.2009
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 19.08.2021
eu-flag.png sk-flag.png